YN321362 Pentagastrin 5534-95-2

Pentagastrin (ICI-50123) is a selective agonist ofCholecystokinin B (CCKB) receptor with an IC50 of 11nM. Pentagastrin enhances gastric mucosal defence mechanisms against acid and protects the gastric mucosa from experimenta...

YN321645 Proglumide 6620-60-6

Proglumide is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide selective blocksCCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion a...

YN321848 Gastrin-1, human 10047-33-3

Gastrin-1, human is the endogenous peptide produced in the stomach, and increases gastric acid secretion viacholecystokinin 2 (CCK2)receptor.

YN321359 Ceruletide 17650-98-5

Ceruletide is a decapeptide and a potentcholecystokinin receptoragonist. Ceruletide is a safe and effective cholecystokinetic agent with a direct spasmogenic effect on the gallbladder muscle and bile ducts.

YN321968 Mini Gastrin I, human 54405-27-5

Mini Gastrin I, human is a shorter version of human gastrin, consists of amino acids 5-17 of the parent peptide.

YN321994 Gastrin-1, rat 81123-06-0

Gastrin-1, rat (Rat Gastrin-17) is a peptide hormone, and can stimulate gastric acid secretion potently.

YN320255 Proglumide hemicalcium 85068-56-0

Proglumide hemicalcium is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide hemicalcium selective blocksCCK’s effects in the central nervous system (CNS). Proglumide hemicalcium has abi...

YN320254 Proglumide sodium 99247-33-3

Proglumide sodium is a nonpeptide and orally activecholecystokinin (CCK)-A/B receptorsantagonist. Proglumide sodium selective blocksCCK’s effects in the central nervous system (CNS). Proglumide sodium has ability to inhibit...

YN320302 Devazepide 103420-77-5

Devazepide (L-364,718) is a potent, competitive, selective and orally active nonpeptide antagonist ofcholecystokinin (CCK) receptor, with IC50s of 81 pM, 45 pM and 245nM for rat pancreatic, bovine gallbladder and guinea pig ...

YN321694 Loxiglumide 107097-80-3

Loxiglumide is a cholecystokinin (CCK-1) receptor antagonist.

YN320663 Dexloxiglumide 119817-90-2

Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist. Dexloxiglumide, the active enantiomer of Loxiglumide, inhibits smooth muscle cell contractions induced by cholecystokinin-octapeptide (CCK-8).

YN320196 Lintitript 136381-85-6

Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptidecholecystokinin (CCK1) receptorantagonist with an EC50 of 6nM and a Ki of 0.2nM. Lintitript displays > 33-fold selectivity more s...

YN322082 CCK-A receptor inhibitor 1 137004-80-9

CCK-A receptor inhibitor 1 is acholecystokinin A(CCK-A)receptorinhibitor with a bingingIC50 of 340nM.

YN322015 Tarazepide 141374-81-4

Tarazepide is a potent and specificCCK-Areceptor antagonist.

YN320667 CCK-B Receptor Antagonis... 155412-88-7

CCK-B Receptor Antagonist 2, compound 15b, is a potent and orally activeGastrin/CCK-Bantagonist with an IC50 value of 0.43nM. CCK-B Receptor Antagonist 2 also inhibits gastrin/CCK-A activity with an IC50 of 1.82...

YN320919 Sograzepide 155488-25-8

Sograzepide (Netazepide; YF 476; YM-220) is an extremely potent , highly selective  and orally activeGastrin/CCK-Bantagonist with an IC50 value of 0.1nM, has inhibitory effect on Gastrin/CCK-A activity with an IC5...

YN322079 Gastrin/CCK antagonist 1 162271-52-5

Gastrin/CCK antagonist 1 is an antagonist ofgastrin/CCK, used for the research of gastrointestinal disorders.

YN322072 CHEMBL333994 167820-10-2

CHEMBL333994 is a potent and orally effective Cholecystokinin A(CCK-A)antagonist, with an IC50 of 0.67nM.

YN322071 CCK-B Receptor Antagonis... 168161-71-5

CCK-B Receptor Antagonist 1 is an antagonist of cholecystokinin B(CCK-B) receptor, and has the potential of reducing the secretion of gastric acid.

YN321169 Nastorazepide 209219-38-5

Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target：CCK-2 in vitro: Z-360 binds to the gastri...